| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Haemonetics Corporation (NYSE: HAE)
HAE Technical Analysis
5
| As on 9th Jun 2023 HAE SHARE Price closed @ 88.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 64.60 & Strong Buy for SHORT-TERM with Stoploss of 53.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HAESHARE Price
| Open | 88.08 | Change | Price | % |
| High | 88.87 | 1 Day | -0.19 | -0.22 |
| Low | 87.56 | 1 Week | 3.54 | 4.18 |
| Close | 88.14 | 1 Month | 5.35 | 6.46 |
| Volume | 181000 | 1 Year | 36.97 | 72.25 |
| 52 Week High 90.60 | 52 Week Low 43.77 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| HAE Daily Charts |
HAE Intraday Charts |
Whats New @ Bazaartrend |
HAE Free Analysis |
|
|
HAE Important Levels Intraday
| RESISTANCE | 90.66 |
| RESISTANCE | 89.85 |
| RESISTANCE | 89.35 |
| RESISTANCE | 88.85 |
| SUPPORT | 87.43 |
| SUPPORT | 86.93 |
| SUPPORT | 86.43 |
| SUPPORT | 85.62 |
HAE Forecast April 2024
| 4th UP Forecast | 119.2 |
| 3rd UP Forecast | 109.24 |
| 2nd UP Forecast | 103.08 |
| 1st UP Forecast | 96.93 |
| 1st DOWN Forecast | 79.35 |
| 2nd DOWN Forecast | 73.2 |
| 3rd DOWN Forecast | 67.04 |
| 4th DOWN Forecast | 57.08 |
HAE Weekly Forecast
| 4th UP Forecast | 93.59 |
| 3rd UP Forecast | 91.84 |
| 2nd UP Forecast | 90.76 |
| 1st UP Forecast | 89.68 |
| 1st DOWN Forecast | 86.60 |
| 2nd DOWN Forecast | 85.52 |
| 3rd DOWN Forecast | 84.44 |
| 4th DOWN Forecast | 82.69 |
HAE Forecast2024
| 4th UP Forecast | 180.4 |
| 3rd UP Forecast | 150.81 |
| 2nd UP Forecast | 132.52 |
| 1st UP Forecast | 114.23 |
| 1st DOWN Forecast | 62.05 |
| 2nd DOWN Forecast | 43.76 |
| 3rd DOWN Forecast | 25.47 |
| 4th DOWN Forecast | -4.12 |
Haemonetics Corporation ( NYSE USA Symbol : HAE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HAE Business Profile
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts. Address: 125 Summer Street, Boston, MA, United States, 02110
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service